{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:58:32Z","timestamp":1781531912851,"version":"3.54.5"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195830"],"award-info":[{"award-number":["1195830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00415-024-12865-5","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:36:10Z","timestamp":1736948170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impulse control disorders in Parkinson\u2019s disease: What\u2019s new?"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-4899","authenticated-orcid":false,"given":"Ana","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"12865_CR1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00702-018-1870-8","volume":"125","author":"A Marques","year":"2018","unstructured":"Marques A, Durif F, Fernagut P (2018) Impulse control disorders in Parkinson\u2019s disease. J Neural Transm (Vienna) 125:1299\u20131312. https:\/\/doi.org\/10.1007\/s00702-018-1870-8","journal-title":"J Neural Transm (Vienna)"},{"key":"12865_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089\u20131096. https:\/\/doi.org\/10.1001\/archneur.64.8.1089","journal-title":"Arch Neurol"},{"key":"12865_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH et al (2015) Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Mov Disord 30:121\u2013127. https:\/\/doi.org\/10.1002\/mds.26016","journal-title":"Mov Disord"},{"key":"12865_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub D, Claassen DO (2017) Impulse control and related disorders in Parkinson\u2019s disease. Int Rev Neurobiol 133:679\u2013717. https:\/\/doi.org\/10.1016\/bs.irn.2017.04.006","journal-title":"Int Rev Neurobiol"},{"key":"12865_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.635494","volume":"12","author":"J-F Zhang","year":"2021","unstructured":"Zhang J-F, Wang X-X, Feng Y et al (2021) Impulse control disorders in Parkinson\u2019s disease: epidemiology, pathogenesis and therapeutic strategies. Front Psychiatry 12:635494. https:\/\/doi.org\/10.3389\/fpsyt.2021.635494","journal-title":"Front Psychiatry"},{"key":"12865_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mdc3.13128","volume":"8","author":"P Parra-D\u00edaz","year":"2021","unstructured":"Parra-D\u00edaz P, Chico-Garc\u00eda JL, Beltr\u00e1n-Corbellini \u00c1 et al (2021) Does the country make a difference in impulse control disorders? A systematic review. Mov Disord Clin Pract 8:25\u201332. https:\/\/doi.org\/10.1002\/mdc3.13128","journal-title":"Mov Disord Clin Pract"},{"key":"12865_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589\u2013595. https:\/\/doi.org\/10.1001\/archneurol.2010.65","journal-title":"Arch Neurol"},{"key":"12865_CR8","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","volume":"91","author":"J-C Corvol","year":"2018","unstructured":"Corvol J-C, Artaud F, Cormier-Dequaire F et al (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189\u2013e201. https:\/\/doi.org\/10.1212\/WNL.0000000000005816","journal-title":"Neurology"},{"key":"12865_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254\u20131257. https:\/\/doi.org\/10.1212\/01.wnl.0000238503.20816.13","journal-title":"Neurology"},{"key":"12865_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","volume":"88","author":"A Antonini","year":"2017","unstructured":"Antonini A, Barone P, Bonuccelli U et al (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:317\u2013324. https:\/\/doi.org\/10.1136\/jnnp-2016-315277","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fneur.2019.00086","volume":"10","author":"RS Eisinger","year":"2019","unstructured":"Eisinger RS, Ramirez-Zamora A, Carbunaru S et al (2019) Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson\u2019s disease. Front Neurol 10:86. https:\/\/doi.org\/10.3389\/fneur.2019.00086","journal-title":"Front Neurol"},{"key":"12865_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mds.27047","volume":"32","author":"DO Claassen","year":"2017","unstructured":"Claassen DO, Stark AJ, Spears CA et al (2017) Mesocorticolimbic hemodynamic response in Parkinson\u2019s disease patients with compulsive behaviors. Mov Disord 32:1574\u20131583. https:\/\/doi.org\/10.1002\/mds.27047","journal-title":"Mov Disord"},{"key":"12865_CR13","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neuroimage.2012.02.006","volume":"60","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Johansson J, Niemel\u00e4 S et al (2012) Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 60:1992\u20131999. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.02.006","journal-title":"Neuroimage"},{"key":"12865_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102259","volume":"27","author":"H Sparks","year":"2020","unstructured":"Sparks H, Riskin-Jones H, Price C et al (2020) Impulsivity relates to relative preservation of mesolimbic connectivity in patients with Parkinson disease. Neuroimage Clin 27:102259. https:\/\/doi.org\/10.1016\/j.nicl.2020.102259","journal-title":"Neuroimage Clin"},{"key":"12865_CR15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/eat.23776","volume":"55","author":"N Leenaerts","year":"2022","unstructured":"Leenaerts N, Jongen D, Ceccarini J et al (2022) The neurobiological reward system and binge eating: a critical systematic review of neuroimaging studies. Int J Eat Disord 55:1421\u20131458. https:\/\/doi.org\/10.1002\/eat.23776","journal-title":"Int J Eat Disord"},{"key":"12865_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/155005941004100208","volume":"41","author":"N Ray","year":"2010","unstructured":"Ray N, Strafella AP (2010) Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson\u2019s disease: insights from functional imaging. Clin EEG Neurosci 41:87\u201393. https:\/\/doi.org\/10.1177\/155005941004100208","journal-title":"Clin EEG Neurosci"},{"key":"12865_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neubiorev.2019.01.008","volume":"98","author":"GM Meyer","year":"2019","unstructured":"Meyer GM, Spay C, Laurencin C et al (2019) Functional imaging studies of impulse control disorders in Parkinson\u2019s disease need a stronger neurocognitive footing. Neurosci Biobehav Rev 98:164\u2013176. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.01.008","journal-title":"Neurosci Biobehav Rev"},{"key":"12865_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans AH, Okai D, Weintraub D et al (2019) Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: critique and recommendations. Mov Disord 34:791\u2013798. https:\/\/doi.org\/10.1002\/mds.27689","journal-title":"Mov Disord"},{"key":"12865_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","volume":"83","author":"K Papay","year":"2014","unstructured":"Papay K, Xie SX, Stern M et al (2014) Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology 83:826\u2013833. https:\/\/doi.org\/10.1212\/WNL.0000000000000729","journal-title":"Neurology"},{"key":"12865_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mds.23501","volume":"26","author":"A Antonini","year":"2011","unstructured":"Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease. Mov Disord 26:464\u2013468. https:\/\/doi.org\/10.1002\/mds.23501","journal-title":"Mov Disord"},{"key":"12865_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","volume":"80","author":"D Weintraub","year":"2013","unstructured":"Weintraub D, Papay K, Siderowf A, Parkinson\u2019s Progression Markers Initiative (2013) Screening for impulse control symptoms in patients with de novo Parkinson disease: a case\u2013ontrol study. Neurology 80:176\u2013180. https:\/\/doi.org\/10.1212\/WNL.0b013e31827b915c","journal-title":"Neurology"},{"key":"12865_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ana.22356","volume":"69","author":"V Voon","year":"2011","unstructured":"Voon V, Sohr M, Lang AE et al (2011) Impulse control disorders in Parkinson disease: a multicenter case\u2013control study. Ann Neurol 69:986\u2013996. https:\/\/doi.org\/10.1002\/ana.22356","journal-title":"Ann Neurol"},{"key":"12865_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s40264-024-01471-z","volume":"47","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli M, Polizzi S, Menestrina L et al (2024) Unveiling the burden of drug-induced impulsivity: a network analysis of the FDA adverse event reporting system. Drug Saf 47:1275\u20131292. https:\/\/doi.org\/10.1007\/s40264-024-01471-z","journal-title":"Drug Saf"},{"key":"12865_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A et al (2014) Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatr 85:840\u2013844. https:\/\/doi.org\/10.1136\/jnnp-2013-306787","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"12865_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/mds.26160","volume":"30","author":"C Siri","year":"2015","unstructured":"Siri C, Cilia R, Reali E et al (2015) Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders. Mov Disord 30:696\u2013704. https:\/\/doi.org\/10.1002\/mds.26160","journal-title":"Mov Disord"},{"key":"12865_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE et al (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380. https:\/\/doi.org\/10.1002\/mds.21770","journal-title":"Mov Disord"},{"key":"12865_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ (2013) Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov Disord 28:327\u2013333. https:\/\/doi.org\/10.1002\/mds.25291","journal-title":"Mov Disord"},{"key":"12865_CR28","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1007\/s00415-023-12170-7","volume":"271","author":"T Wirth","year":"2024","unstructured":"Wirth T, Goetsch T, Corvol J-C et al (2024) Prognosis of impulse control disorders in Parkinson\u2019s disease: a prospective controlled study. J Neurol 271:2412\u20132422. https:\/\/doi.org\/10.1007\/s00415-023-12170-7","journal-title":"J Neurol"},{"key":"12865_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.02.017","volume":"25","author":"S Nakum","year":"2016","unstructured":"Nakum S, Cavanna AE (2016) The prevalence and clinical characteristics of hypersexuality in patients with Parkinson\u2019s disease following dopaminergic therapy: a systematic literature review. Parkinsonism Relat Disord 25:10\u201316. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.02.017","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2024-300998","volume":"27","author":"N Tayim","year":"2024","unstructured":"Tayim N, Barbosa P, Panicker J (2024) Hypersexuality in neurological disorders: a systematic review. BMJ Ment Health 27:e300998. https:\/\/doi.org\/10.1136\/bmjment-2024-300998","journal-title":"BMJ Ment Health"},{"key":"12865_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.parkreldis.2012.10.017","volume":"19","author":"B Pereira","year":"2013","unstructured":"Pereira B, Llorca PM, Durif F et al (2013) Screening hypersexuality in Parkinson\u2019s disease in everyday practice. Parkinsonism Relat Disord 19:242\u2013246. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.10.017","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-019-00648-1","author":"I de Chazeron","year":"2019","unstructured":"de Chazeron I, Durif F, Chereau-Boudet I et al (2019) Compulsive eating behaviors in Parkinson\u2019s disease. Eat Weight Disord. https:\/\/doi.org\/10.1007\/s40519-019-00648-1","journal-title":"Eat Weight Disord"},{"key":"12865_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/mds.20757","volume":"21","author":"MJ Nirenberg","year":"2006","unstructured":"Nirenberg MJ, Waters C (2006) Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21:524\u2013529. https:\/\/doi.org\/10.1002\/mds.20757","journal-title":"Mov Disord"},{"key":"12865_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/jnp.23.1.jnp56","volume":"23","author":"LB Zahodne","year":"2011","unstructured":"Zahodne LB, Susatia F, Bowers D et al (2011) Binge eating in Parkinson\u2019s disease: prevalence, correlates and the contribution of deep brain stimulation. J Neuropsychiatry Clin Neurosci 23:56\u201362. https:\/\/doi.org\/10.1176\/jnp.23.1.jnp56","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"12865_CR35","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1038\/s41598-021-90266-8","volume":"11","author":"I de Chazeron","year":"2021","unstructured":"de Chazeron I, Durif F, Lambert C et al (2021) A case\u2013control study investigating food addiction in Parkinson patients. Sci Rep 11:10934. https:\/\/doi.org\/10.1038\/s41598-021-90266-8","journal-title":"Sci Rep"},{"key":"12865_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","volume":"19","author":"G Santangelo","year":"2013","unstructured":"Santangelo G, Barone P, Trojano L, Vitale C (2013) Pathological gambling in Parkinson\u2019s disease. A comprehensive review. Parkinsonism Relat Disord 19:645\u2013653. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.02.007","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR37","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M et al (2006) Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66:1750\u20131752. https:\/\/doi.org\/10.1212\/01.wnl.0000218206.20920.4d","journal-title":"Neurology"},{"key":"12865_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/archneur.64.2.212","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Thomsen T, Miyasaki JM et al (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212\u2013216. https:\/\/doi.org\/10.1001\/archneur.64.2.212","journal-title":"Arch Neurol"},{"key":"12865_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mds.23480","volume":"26","author":"R Cilia","year":"2011","unstructured":"Cilia R, Cho SS, van Eimeren T et al (2011) Pathological gambling in patients with Parkinson\u2019s disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov Disord 26:225\u2013233. https:\/\/doi.org\/10.1002\/mds.23480","journal-title":"Mov Disord"},{"key":"12865_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mds.23567","volume":"26","author":"C Vitale","year":"2011","unstructured":"Vitale C, Santangelo G, Trojano L et al (2011) Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson\u2019s disease. Mov Disord 26:830\u2013836. https:\/\/doi.org\/10.1002\/mds.23567","journal-title":"Mov Disord"},{"key":"12865_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.07.010","author":"A Kim","year":"2018","unstructured":"Kim A, Kim YE, Kim H-J et al (2018) A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.010","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neubiorev.2013.02.002","volume":"37","author":"G Sescousse","year":"2013","unstructured":"Sescousse G, Cald\u00fa X, Segura B, Dreher J-C (2013) Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies. Neurosci Biobehav Rev 37:681\u2013696. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.02.002","journal-title":"Neurosci Biobehav Rev"},{"key":"12865_CR43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/mds.26199","volume":"30","author":"L Tremblay","year":"2015","unstructured":"Tremblay L, Worbe Y, Thobois S et al (2015) Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 30:1155\u20131170. https:\/\/doi.org\/10.1002\/mds.26199","journal-title":"Mov Disord"},{"key":"12865_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","volume":"8","author":"V Voon","year":"2009","unstructured":"Voon V, Fernagut P-O, Wickens J et al (2009) Chronic dopaminergic stimulation in Parkinson\u2019s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140\u20131149. https:\/\/doi.org\/10.1016\/S1474-4422(09)70287-X","journal-title":"Lancet Neurol"},{"key":"12865_CR45","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1212\/WNL.30.12.1326","volume":"30","author":"F Javoy-Agid","year":"1980","unstructured":"Javoy-Agid F, Agid Y (1980) Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 30:1326\u20131326. https:\/\/doi.org\/10.1212\/WNL.30.12.1326","journal-title":"Neurology"},{"key":"12865_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2013.12.021","volume":"262","author":"O Ouachikh","year":"2014","unstructured":"Ouachikh O, Dieb W, Durif F, Hafidi A (2014) Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats. Behav Brain Res 262:1\u20137. https:\/\/doi.org\/10.1016\/j.bbr.2013.12.021","journal-title":"Behav Brain Res"},{"key":"12865_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2013.05.042","volume":"252","author":"O Ouachikh","year":"2013","unstructured":"Ouachikh O, Dieb W, Durif F, Hafidi A (2013) Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area. Behav Brain Res 252:24\u201331. https:\/\/doi.org\/10.1016\/j.bbr.2013.05.042","journal-title":"Behav Brain Res"},{"key":"12865_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2014.04.026","volume":"282","author":"S Nakanishi","year":"2014","unstructured":"Nakanishi S, Hikida T, Yawata S (2014) Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors. Neuroscience 282:49\u201359. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.026","journal-title":"Neuroscience"},{"key":"12865_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neurol.2019.11.002","volume":"176","author":"A Draoui","year":"2020","unstructured":"Draoui A, El Hiba O, Aimrane A et al (2020) Parkinson\u2019s disease: from bench to bedside. Rev Neurol 176:543\u2013559. https:\/\/doi.org\/10.1016\/j.neurol.2019.11.002","journal-title":"Rev Neurol"},{"key":"12865_CR50","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TDL Steeves","year":"2009","unstructured":"Steeves TDL, Miyasaki J, Zurowski M et al (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376\u20131385. https:\/\/doi.org\/10.1093\/brain\/awp054","journal-title":"Brain"},{"key":"12865_CR51","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1523\/JNEUROSCI.3082-17.2018","volume":"38","author":"AJ Stark","year":"2018","unstructured":"Stark AJ, Smith CT, Lin Y-C et al (2018) Nigrostriatal and mesolimbic D2\/3 receptor expression in Parkinson\u2019s disease patients with compulsive reward-driven behaviors. J Neurosci 38:3230\u20133239. https:\/\/doi.org\/10.1523\/JNEUROSCI.3082-17.2018","journal-title":"J Neurosci"},{"key":"12865_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mds.26135","volume":"30","author":"DE Payer","year":"2015","unstructured":"Payer DE, Guttman M, Kish SJ et al (2015) [11C]-(+)-PHNO PET imaging of dopamine D2\/3 receptors in Parkinson\u2019s disease with impulse control disorders. Mov Disord 30:160\u2013166. https:\/\/doi.org\/10.1002\/mds.26135","journal-title":"Mov Disord"},{"key":"12865_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.654238","volume":"15","author":"A Augustine","year":"2021","unstructured":"Augustine A, Winstanley CA, Krishnan V (2021) Impulse control disorders in Parkinson\u2019s disease: from bench to bedside. Front Neurosci 15:654238. https:\/\/doi.org\/10.3389\/fnins.2021.654238","journal-title":"Front Neurosci"},{"key":"12865_CR54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS et al (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis 39:98\u2013104. https:\/\/doi.org\/10.1016\/j.nbd.2010.03.013","journal-title":"Neurobiol Dis"},{"key":"12865_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R et al (2014) Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry 85:148\u2013152. https:\/\/doi.org\/10.1136\/jnnp-2013-305395","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR56","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00259-019-04396-3","volume":"46","author":"I Navalpotro-Gomez","year":"2019","unstructured":"Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F et al (2019) Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson\u2019s disease patients with impulse control disorders. Eur J Nucl Med Mol Imaging 46:2065\u20132076. https:\/\/doi.org\/10.1007\/s00259-019-04396-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12865_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2013-305549","volume":"85","author":"J-Y Lee","year":"2014","unstructured":"Lee J-Y, Seo SH, Kim YK et al (2014) Extrastriatal dopaminergic changes in Parkinson\u2019s disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry 85:23\u201330. https:\/\/doi.org\/10.1136\/jnnp-2013-305549","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J et al (2014) Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord 29:904\u2013911. https:\/\/doi.org\/10.1002\/mds.25886","journal-title":"Mov Disord"},{"key":"12865_CR59","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864\u2013870. https:\/\/doi.org\/10.1136\/jnnp-2015-311827","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/awz007","volume":"142","author":"J Hammes","year":"2019","unstructured":"Hammes J, Theis H, Giehl K et al (2019) Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain 142:733\u2013743. https:\/\/doi.org\/10.1093\/brain\/awz007","journal-title":"Brain"},{"key":"12865_CR61","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/WNL.0000000000001619","volume":"84","author":"N Carriere","year":"2015","unstructured":"Carriere N, Lopes R, Defebvre L et al (2015) Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology 84:2116\u20132123. https:\/\/doi.org\/10.1212\/WNL.0000000000001619","journal-title":"Neurology"},{"key":"12865_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2018.00279","volume":"9","author":"MFL Ruitenberg","year":"2018","unstructured":"Ruitenberg MFL, Wu T, Averbeck BB et al (2018) Impulsivity in Parkinson\u2019s disease is associated with alterations in affective and sensorimotor striatal networks. Front Neurol 9:279. https:\/\/doi.org\/10.3389\/fneur.2018.00279","journal-title":"Front Neurol"},{"key":"12865_CR63","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.27139","volume":"32","author":"A Tessitore","year":"2017","unstructured":"Tessitore A, De Micco R, Giordano A et al (2017) Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson\u2019s disease. Mov Disord 32:1710\u20131719. https:\/\/doi.org\/10.1002\/mds.27139","journal-title":"Mov Disord"},{"key":"12865_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fneur.2018.00163","volume":"9","author":"M Mojtahed Zadeh","year":"2018","unstructured":"Mojtahed Zadeh M, Ashraf-Ganjouei A, Ghazi Sherbaf F et al (2018) White matter tract alterations in drug-na\u00efve Parkinson\u2019s disease patients with impulse control disorders. Front Neurol 9:163. https:\/\/doi.org\/10.3389\/fneur.2018.00163","journal-title":"Front Neurol"},{"key":"12865_CR65","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/brain\/awt027","volume":"136","author":"JPM van der Vegt","year":"2013","unstructured":"van der Vegt JPM, Hulme OJ, Zittel S et al (2013) Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson\u2019s disease. Brain 136:1192\u20131203. https:\/\/doi.org\/10.1093\/brain\/awt027","journal-title":"Brain"},{"key":"12865_CR66","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neurobiolaging.2014.07.031","volume":"36","author":"C Vriend","year":"2015","unstructured":"Vriend C, Gerrits NJHM, Berendse HW et al (2015) Failure of stop and go in de novo Parkinson\u2019s disease\u2014a functional magnetic resonance imaging study. Neurobiol Aging 36:470\u2013475. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.031","journal-title":"Neurobiol Aging"},{"key":"12865_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cortex.2017.06.008","volume":"94","author":"A Tessitore","year":"2017","unstructured":"Tessitore A, Santangelo G, De Micco R et al (2017) Resting-state brain networks in patients with Parkinson\u2019s disease and impulse control disorders. Cortex 94:63\u201372. https:\/\/doi.org\/10.1016\/j.cortex.2017.06.008","journal-title":"Cortex"},{"key":"12865_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10498-6","author":"A Marques","year":"2021","unstructured":"Marques A, Roquet D, Matar E et al (2021) Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10498-6","journal-title":"J Neurol"},{"key":"12865_CR69","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mds.27668","volume":"34","author":"D Weintraub","year":"2019","unstructured":"Weintraub D (2019) Impulse control disorders in Parkinson\u2019s disease: a 20-year odyssey. Mov Disord 34:447\u2013452. https:\/\/doi.org\/10.1002\/mds.27668","journal-title":"Mov Disord"},{"key":"12865_CR70","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.25581","volume":"86","author":"J Mar\u00edn-Lahoz","year":"2019","unstructured":"Mar\u00edn-Lahoz J, Sampedro F, Martinez-Horta S et al (2019) Depression as a risk factor for impulse control disorders in Parkinson disease. Ann Neurol 86:762\u2013769. https:\/\/doi.org\/10.1002\/ana.25581","journal-title":"Ann Neurol"},{"key":"12865_CR71","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/JPD-212959","volume":"12","author":"P Waskowiak","year":"2022","unstructured":"Waskowiak P, Koppelmans V, Ruitenberg MFL (2022) Trait anxiety as a risk factor for impulse control disorders in de novo Parkinson\u2019s disease. JPD 12:689\u2013697. https:\/\/doi.org\/10.3233\/JPD-212959","journal-title":"JPD"},{"key":"12865_CR72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jnnp-2014-307904","volume":"86","author":"M Fantini","year":"2015","unstructured":"Fantini M, Macedo L, Zibetti M et al (2015) Increased risk of impulse control symptoms in Parkinson\u2019s disease with REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry 86:174\u2013179. https:\/\/doi.org\/10.1136\/jnnp-2014-307904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/jnnp-2017-316576","volume":"89","author":"M Fantini","year":"2018","unstructured":"Fantini M, Figorilli M, Arnulf I et al (2018) Sleep and REM sleep behaviour disorder in Parkinson\u2019s disease with impulse control disorder. J Neurol Neurosurg Psychiatry 89:305\u2013310. https:\/\/doi.org\/10.1136\/jnnp-2017-316576","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12865_CR74","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P (2024) Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord 122:106101. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106101","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR75","doi-asserted-by":"publisher","first-page":"1275170","DOI":"10.3389\/fneur.2023.1275170","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu X, Gan J, Wu N et al (2023) Assessing impulse control behaviors in early Parkinson\u2019s disease: a longitudinal study. Front Neurol 14:1275170. https:\/\/doi.org\/10.3389\/fneur.2023.1275170","journal-title":"Front Neurol"},{"key":"12865_CR76","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00702-012-0934-4","volume":"120","author":"F Cormier","year":"2013","unstructured":"Cormier F, Muellner J, Corvol J-C (2013) Genetics of impulse control disorders in Parkinson\u2019s disease. J Neural Transm (Vienna) 120:665\u2013671. https:\/\/doi.org\/10.1007\/s00702-012-0934-4","journal-title":"J Neural Transm (Vienna)"},{"key":"12865_CR77","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/mds.27519","volume":"33","author":"F Cormier-Dequaire","year":"2018","unstructured":"Cormier-Dequaire F, Bekadar S, Anheim M et al (2018) Suggestive association between OPRM1 and impulse control disorders in Parkinson\u2019s disease. Mov Disord 33:1878\u20131886. https:\/\/doi.org\/10.1002\/mds.27519","journal-title":"Mov Disord"},{"key":"12865_CR78","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","volume":"87","author":"J Kraemmer","year":"2016","unstructured":"Kraemmer J, Smith K, Weintraub D et al (2016) Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatr 87:1106\u20131111. https:\/\/doi.org\/10.1136\/jnnp-2015-312848","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"12865_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2021.100113","volume":"5","author":"A Hall","year":"2021","unstructured":"Hall A, Weaver SR, Compton LJ et al (2021) Dopamine genetic risk score predicts impulse control behaviors in Parkinson\u2019s disease. Clin Parkinsonism Relat Disord 5:100113. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100113","journal-title":"Clin Parkinsonism Relat Disord"},{"key":"12865_CR80","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/acn3.51569","volume":"9","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Posavi M, Fontanillas P et al (2022) Genetic prediction of impulse control disorders in Parkinson\u2019s disease. Ann Clin Transl Neurol 9:936\u2013949. https:\/\/doi.org\/10.1002\/acn3.51569","journal-title":"Ann Clin Transl Neurol"},{"key":"12865_CR81","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord 24:1461\u20131467. https:\/\/doi.org\/10.1002\/mds.22571","journal-title":"Mov Disord"},{"key":"12865_CR82","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K et al (2012) Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov Disord 27:242\u2013247. https:\/\/doi.org\/10.1002\/mds.24023","journal-title":"Mov Disord"},{"key":"12865_CR83","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mds.26223","volume":"30","author":"I Rieu","year":"2015","unstructured":"Rieu I, Martinez-Martin P, Pereira B et al (2015) International validation of a behavioral scale in Parkinson\u2019s disease without dementia. Mov Disord 30:705\u2013713. https:\/\/doi.org\/10.1002\/mds.26223","journal-title":"Mov Disord"},{"key":"12865_CR84","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","volume":"165","author":"C Ardouin","year":"2009","unstructured":"Ardouin C, Ch\u00e9reau I, Llorca P-M et al (2009) Assessment of hyper- and hypodopaminergic behaviors in Parkinson\u2019s disease. Rev Neurol 165:845\u2013856. https:\/\/doi.org\/10.1016\/j.neurol.2009.06.003","journal-title":"Rev Neurol"},{"key":"12865_CR85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","volume":"265","author":"SR Chamberlain","year":"2018","unstructured":"Chamberlain SR, Grant JE (2018) Minnesota impulse disorders interview (MIDI): validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample. Psychiatry Res 265:279\u2013283. https:\/\/doi.org\/10.1016\/j.psychres.2018.05.006","journal-title":"Psychiatry Res"},{"key":"12865_CR86","volume-title":"Iowa gambling task professional manual","author":"A Bechara","year":"2007","unstructured":"Bechara A (2007) Iowa gambling task professional manual. Psychological Assessment Resources Inc, Lutz"},{"key":"12865_CR87","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1523\/JNEUROSCI.0519-07.2007","volume":"27","author":"AR Aron","year":"2007","unstructured":"Aron AR, Behrens TE, Smith S et al (2007) Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J Neurosci 27:3743\u20133752. https:\/\/doi.org\/10.1523\/JNEUROSCI.0519-07.2007","journal-title":"J Neurosci"},{"key":"12865_CR88","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","volume":"80","author":"D Okai","year":"2013","unstructured":"Okai D, Askey-Jones S, Samuel M et al (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology 80:792\u2013799. https:\/\/doi.org\/10.1212\/WNL.0b013e3182840678","journal-title":"Neurology"},{"key":"12865_CR89","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.parkreldis.2012.06.005","volume":"18","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Vahlberg T, Kaasinen V (2012) Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 18:1079\u20131083. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.06.005","journal-title":"Parkinsonism Relat Disord"},{"key":"12865_CR90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archneurol.2009.294","volume":"67","author":"CA Rabinak","year":"2010","unstructured":"Rabinak CA, Nirenberg MJ (2010) Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67:58\u201363. https:\/\/doi.org\/10.1001\/archneurol.2009.294","journal-title":"Arch Neurol"},{"key":"12865_CR91","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/WNF.0000000000000091","volume":"38","author":"A Todorova","year":"2015","unstructured":"Todorova A, Samuel M, Brown RG, Chaudhuri KR (2015) Infusion therapies and development of impulse control disorders in advanced Parkinson disease: clinical experience after 3 years\u2019 follow-up. Clin Neuropharmacol 38:132\u2013134. https:\/\/doi.org\/10.1097\/WNF.0000000000000091","journal-title":"Clin Neuropharmacol"},{"key":"12865_CR92","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00415-018-8803-1","volume":"265","author":"MJ Catalan","year":"2018","unstructured":"Catalan MJ, Molina-Arjona JA, Mir P et al (2018) Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson\u2019s disease. J Neurol 265:1279\u20131287. https:\/\/doi.org\/10.1007\/s00415-018-8803-1","journal-title":"J Neurol"},{"key":"12865_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12576-x","author":"K Witt","year":"2024","unstructured":"Witt K, Levin J, van Eimeren T et al (2024) Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations\u2014guideline \u201cParkinson\u2019s disease\u201d of the German Society of Neurology. J Neurol. https:\/\/doi.org\/10.1007\/s00415-024-12576-x","journal-title":"J Neurol"},{"key":"12865_CR94","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s00415-023-11814-y","volume":"270","author":"C Laurencin","year":"2023","unstructured":"Laurencin C, Timestit N, Marques A et al (2023) Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson\u2019s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. J Neurol 270:4851\u20134859. https:\/\/doi.org\/10.1007\/s00415-023-11814-y","journal-title":"J Neurol"},{"key":"12865_CR95","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"A Thomas","year":"2010","unstructured":"Thomas A, Bonanni L, Gambi F et al (2010) Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 68:400\u2013404. https:\/\/doi.org\/10.1002\/ana.22029","journal-title":"Ann Neurol"},{"key":"12865_CR96","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.22164","volume":"68","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Sohr M, Potenza MN et al (2010) Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 68:963\u2013968. https:\/\/doi.org\/10.1002\/ana.22164","journal-title":"Ann Neurol"},{"key":"12865_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mdc3.12167","volume":"2","author":"J Liang","year":"2015","unstructured":"Liang J, Groves M, Shanker VL (2015) Clozapine treatment for impulse control disorders in Parkinson\u2019s disease patients: a case series. Mov Disord Clin Pract 2:283\u2013285. https:\/\/doi.org\/10.1002\/mdc3.12167","journal-title":"Mov Disord Clin Pract"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12865-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:42:04Z","timestamp":1739637724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12865-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12865"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12865-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"138"}}